Chemotherapy and pregnancy

Clinical Obstetrics and Gynecology

Volumn 45, Issue 1, 2002, Pages 153-164

  Leslie, Kimberly K ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; BLEOMYCIN; BLEOMYCIN SULFATE; BUSULFAN; CARBOPLATIN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DACTINOMYCIN; DAUNORUBICIN; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; GYRASE INHIBITOR; IRINOTECAN; MELPHALAN; METHOTREXATE; NUCLEOSIDE ANALOG; TAXANE DERIVATIVE; THIOTEPA; TOPOTECAN; UNINDEXED DRUG; VINCA ALKALOID; VINCRISTINE SULFATE;

ADULT; CANCER CHEMOTHERAPY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MECHANISM; FETOTOXICITY; FETUS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PREGNANCY; PRENATAL DRUG EXPOSURE; REVIEW;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIBODIES, MONOCLONAL; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ENZYME INHIBITORS; ETOPOSIDE; FEMALE; FETUS; HUMANS; NUCLEIC ACID SYNTHESIS INHIBITORS; PACLITAXEL; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; TOPOTECAN; VINBLASTINE; VINCRISTINE;

EID: 0036198095     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200203000-00015     Document Type: Review

References (49)

1. Metastasis of maternal cancer to the placenta and fetus
2. Chemotherapy in pregnancy
3. Cancer in pregnancy: A review of the literature. Part I
4. Apparent cyclophosphamide (Cytoxan) embryopathy: A distinct phenotype?
5. The fertility and pregnancy outcomes of the patients who underwent preservative operation followed by adjuvant chemotherapy for malignant ovarian tumors
6. Pregnancy and leukaemia
7. Possible teratogenic effect of chlorambucil in a human fetus
8. Renal agenesis after first trimester exposure to chlorambucil
9. Cytotoxic drugs in pregnancy: Review of reported cases
10. Leukemia during pregnancy
11. Transplacental transmission of busulfan in a mother with leukemia: Production of fetal malformation and cytomegaly
12. Myeloschisis in a six week embryo of a leukemic woman treated by busulfan
13. Chemotherapy in the treatment of locally advanced cervical cancer and pregnancy
14. The transfer of drugs and other chemicals into human milk
15. Excretion of platinum into breast milk
16. Chemotherapy for malignant melanoma during pregnancy
17. The effects of cancer chemotherapeutic agents on the developing fetus
18. Multiagent chemotherapy for sarcoma diagnosed during pregnancy
19. Recurrent endodermal sinus tumor during pregnancy
20. Maternal and fetal survival following surgery and chemotherapy of endodermal sinus tumor of the ovary during pregnancy: A case report
21. Cytogenic effects of bleomycin therapy in man
22. Multiple agent chemotherapy including bleomycin of non-Hodgkin's lymphoma during pregnancy
23. Non-Hodgkin's lymphoma in pregnancy
24. Methotrexate-induced congenital malformations
25. Methotrexate-induced congenital malformations
26. Teratogenicity of folic acid antagonists
27. Symptom control in the pregnant cancer patient
28. Multiple congenital anomalies in a fetus exposed to 5-fluorouracil during the first trimester
29. Congenital abnormalities in a baby born to cytarabine treated mother
30. Teratogenic effects of antileukemic chemotherapy
31. Acute leukaemia during pregnancy
32. Conservative surgical management of dysgerminoma concomitant with pregnancy
33. Fetal marrow suppression after maternal chemotherapy for leukaemia
34. Multimodal cancer therapy for breast cancer in the first trimester of pregnancy. A case report
35. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: Case report and review of the literature
36. Doxorubicin and cisplatin excretion into human milk
37. The investigation and management of Hodgkin's disease in the pregnant patient
38. Fetal renal malformation following treatment of Hodgkin's disease during pregnancy
39. Treatment of acute leukemia during pregnancy: Presentation of nine cases
40. Teratogenic effects of combination chemotherapy
41. Antitumor effects of doxorubicin in combination with anbtiepidermal growth factor receptor monoclonal antibodies
42. Addition of herceptin (humanized anti-HER2 antibody) to first-line chemotherapy for HER2 overexpressing metastatic breast cancer markedly increases anticancer activity: A randomized, multinational controlled phase III trial
43. Management of breast cancer during pregnancy using a standard protocol
44. Management of cancer during pregnancy
45. Chemotherapy in treatment of non-Hodgkin's lymphoma in pregnancy
46. Pregnancy and leukemia
47. Lymphoma and leukemia complicating pregnancy
48. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood